Welcome to the Department of Health Care Services Welcome to Medi-Cal Welcome to the Department of Health Care Services

Medi-Cal Logo
Click to Sign Up for MCSS emails

Brand Name Abilify 2 mg to Remain Labeler Restricted

August 15, 2016

On July 15, 2016, pharmacy claims for brand name Abilify 2 mg NDC 59148-0006-13 began erroneously reimbursing at the Federal Upper Limit (FUL) reimbursement rate while a Department of Health Care Services (DHCS) labeler restriction policy was in place.

System changes have been made to remove the FUL reimbursement from Abilify 2 mg NDC 59148-0006-13 retroactive to July 15, 2016. Beginning August 15, 2016, pharmacy providers may reverse and rebill any transactions for Abilify 2 mg NDC 59148-0006-13 with a date of service from July 15, 2016, to August 14, 2016, in order to receive the appropriate reimbursement.